Actively Recruiting
Evaluating the Impact of a Functional and Cognitive Strategy in Patients With Long Covid-19
Led by Fundación Cardioinfantil Instituto de Cardiología · Updated on 2026-04-13
374
Participants Needed
1
Research Sites
61 weeks
Total Duration
On this page
Sponsors
F
Fundación Cardioinfantil Instituto de Cardiología
Lead Sponsor
H
Hospital Militar Central, Colombia
Collaborating Sponsor
AI-Summary
What this Trial Is About
This study aims to evaluate the impact of a functional and cognitive rehabilitation strategy compared to evidence-based informational messages, on functional capacity, cognitive abilities, quality of life, and disease progression in adults with chronic non-communicable diseases (NCDs) and Long Covid-19. Researchers will compare a structured rehabilitation program to informational support through evidence-based messages to determine if rehabilitation leads to better functional and cognitive outcomes in patients with Long Covid-19. Participants will be randomly assigned to one of two groups: 1. Functional and cognitive rehabilitation: Attending weekly in-person sessions for 8 weeks, including supervised physical and cognitive exercises. 2. Informational support: Receiving weekly evidence-based educational messages for 8 weeks. Participants will undergo assessments at baseline, post-intervention, and six months later, including a six-minute walk test, handgrip strength measurement, and questionnaires on disability, anxiety, depression, fatigue, dyspnea, cognitive function, and quality of life.
CONDITIONS
Official Title
Evaluating the Impact of a Functional and Cognitive Strategy in Patients With Long Covid-19
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Confirmed diagnosis of Covid-19.
- History of arterial hypertension or diabetes mellitus prior to SARS-CoV-2 infection.
- Presence of two or more concurrent symptoms related to prolonged Covid-19 lasting at least 4 weeks.
- At least one symptom impacts daily activities, including physical or neuropsychiatric symptoms.
- Symptoms not explained by pre-existing conditions.
- Ability to read and participate in in-person rehabilitation sessions or receive informational messages.
You will not qualify if you...
- Age over 80 years.
- Severely advanced medical conditions prior to SARS-CoV-2 infection.
- Chronic respiratory disease requiring supplemental oxygen.
- Heart failure with left ventricular ejection fraction less than 40%.
- Advanced kidney disease with glomerular filtration rate below 30.
- Two hospitalizations in the year before registry admission for underlying disease.
- Dependence on a caregiver.
- Orthopedic or cardiopulmonary conditions preventing aerobic exercise.
- Neuropsychiatric or cognitive impairments limiting understanding or participation in cognitive exercises.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Fundación Cardioinfantil-Instituto de cardiología
Bogotá, Bogotá DC, Colombia, 110131
Actively Recruiting
Research Team
K
Karen J Moreno, PT MSc
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here